Featured Articles
-
Prevent Costly Bag Leaks In Single-Use Manufacturing
5/12/2023
In the biopharmaceutical industry, bag leaks remain a top pain point for customers. Ultimus® film addresses this costly issue, offering superior protection against leaks, abrasions, tears, and material fatigue.
-
Demonstrated Strength And Durability Of UltimusĀ® Film
5/12/2023
Here, we outline the development of Ultimus® film and summarize the strength and robustness tests conducted in accordance with the American Society for Testing and Materials (ASTM).
-
How Data Analytics Accelerates Transition To Bioprocessing 4.0
4/7/2023
Following successful Industry 4.0 implementation in the automotive, communications, aerospace, and other industries, the biopharma industry is now joining the digital revolution.
-
Application Of A Sf-Rhabdovirus-Negative Platform For AAV Production
3/10/2023
Discover a two-part system comprising a proven Sf-9 cell line devoid of Sf-rhabdovirus and a chemically defined medium engineered for it. Explore the performance of this medium for AAV2 production.
-
mRNA Process And Cost Modeling: A Tool To Optimize Process Development
3/10/2023
Demand for mRNA-based medicine production continues to increase, as do investments in prophylactic and therapeutic indications. Explore a cost-model that compares all modalities.
-
Applying High Throughput Processes To Optimize AAV Titers
3/8/2023
A growing number of AAV product developers are recognizing the value in moving to suspension as early in development as possible in order to optimize production.
-
Viral Safety Handbook
3/6/2023
Since production templates depend on cell culture processes, biopharmaceuticals are susceptible to adventitious agent contamination. Explore a holistic overview of viral safety consolidating decades of expertise and process understanding.
-
Chromatography Solutions For AAV Full And Empty Capsid Separation
3/1/2023
Effective separation of full and empty AAV capsids requires implementation of purification strategies that differ from standard approaches used for traditional modalities. Explore two cases describing such approaches.
-
Orthogonal Methods To Understand And Define CQAs Of AAV Therapies
2/24/2023
An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.
-
Next Generation Sequencing For Adventitious Agent Detection In Cell Banks
2/23/2023
NGS-based methods for agnostic broad range detection are suitable options to augment or replace current virus testing methodology. Explore a NGS AAT method for cell line characterization and more.